(Source: NIH - National Institutes of Health) News Release Monday, April 18, 2016 NIH-funded study lays groundwork for potential application submission to FDA for licensure of islet preparation. New clinical trial results show that transplantation of pancreatic islets - cell clusters that contain insulin-producing cells-prevents severe, potentially life-threatening drops in blood sugar in people with type 1 diabetes. Researchers found that the treatment was effective for people who experienced episodes of severe hypoglycemia - low blood sugar levels that can lead to seizures, loss of consciousness and death - despite receiving expert care. The Phase 3 trial was funded by the National...
↧